BRCA1\2 mutation carriers undergoing RRSO have different risk factors from women who experience primary menopause: the genetic susceptibility to cancer is mitigated by a younger age at the onset of hormone deficiency, a shorter hormone exposure time and an increased number of clinical evaluations because of screening. Here, BRCA1 is linked to cancer.